1. Introduction
Substantial evidence demonstrates that supplemental intake of dietary fiber provides various health benefits and reduces the risk of developing coronary heart disease, stroke, hypertension, diabetes, and certain intestinal diseases. As a dietary fiber is resistant to digestive enzyme activity, it passes through the small intestine structurally intact and reaches the colon. In the colon, dietary fibers affect the composition and metabolism of intestinal microbiota [
1]. Accordingly, dietary fiber supplementation often has physiological effects in a microbiota-dependent manner [
2], while dietary fibers directly interact with the intestinal epithelium to affect cellular functions. For example, fructans, including inulin and fructooligosaccharides, protect the intestinal barrier via the protein kinase C pathway [
3]. Guar gum fibers reduce the inflammatory reaction via toll-like receptor-2 (TLR-2) and dectin-1 activation [
4]. These observations suggest that certain dietary fibers play a role in maintaining intestinal homeostasis in an intestinal microbiota-independent manner; however, the precise mechanisms remain unclear.
Psyllium fiber is produced from the seed husk of
Plantago ovata and contains soluble and insoluble fibers with a high quantity of hemicellulose, which consists of a xylan backbone associated with rhamnose, arabinose, and galacturonic acid units (arabinoxylan). Highly branched arabinoxylan is characterized by high water holding and gel formation abilities, which are associated with the physiological effects of psyllium fibers, such as the reduction of sugar and lipid absorption and anti-constipation action [
5]. Psyllium supplementation reduces intestinal inflammation induced by a high-fat diet and dextran sulfate sodium in mice [
6,
7]. In addition, Hino et al., showed that psyllium supplementation increases the number of mucin-producing goblet cells and mucin secretion in the small intestine of the rat, where intestinal bacterial activity is relatively low [
8]. Although different mechanisms underlying psyllium-mediated actions may exist [
9], psyllium appears to directly interact with intestinal epithelial cells to regulate intestinal function.
Intestinal epithelial cells are responsible for the digestion and absorption of nutrients whilst serving as a barrier to eliminate the permeation of luminal inflammatory substances, including bacteria, helminths, and viruses, into the internal environment of the body. The intestinal barrier is generally composed of chemical (antimicrobial proteins and immunoglobulin A) and physical (intercellular tight junctions and mucus layers) barriers [
10]. Several antimicrobial proteins such as defensins, regenerating islet-derived protein 3 (REG3), small proline-rich protein 2A (SPRR2A), resistin-like beta (RELMβ) are produced in the intestine. Antimicrobial proteins protect against pathogenic bacteria to prevent infections [
1] and are key determinants of intestinal microbiota composition. Accumulating evidence indicates that the regulation of intestinal antimicrobial protein production is associated with several diseases such as infection, inflammatory bowel diseases, and obesity. Antimicrobial proteins exhibit a site-specific spectrum of antimicrobial activity and expression in the small and large intestines [
11]. SPRR2A and RELMβ are primarily produced by Paneth and goblet cells in response to type II immunity [
12]. SPRR2A is a bactericidal protein that targets gram-positive bacteria [
13]. Its intestinal expression increases during helminth infections and commensal bacteria colonization, suggesting that it plays a role in both helminth clearance and microbial composition. In contrast, RELMβ targets gram-negative bacteria and promotes spatial segregation of the microbiota and intestinal epithelium [
14]. Type II cytokines, IL-4 and IL-13, stimulate the production of SPRR2A and RELMβ in the intestines [
13,
15]. Thus, regulating intestinal antimicrobial proteins may be a novel approach to promote the human health.
The intestinal epithelium is composed of several cell types such as enterocytes, goblet cells, enteroendocrine cells, Paneth cells, and tuft cells, with varying abundances. Tuft cells, accounting for <1% of the total intestinal epithelial cells [
16], are relatively rare. Nevertheless, tuft cells play an important role in regulating intestinal homeostasis and serve as key epithelial sentinels that initiate type II mucosal immunity during parasitic and bacterial infections [
17]. During helminth infection, tuft cells produce IL-25 to activate group II innate lymphoid cells (ILC2) in the lamina propria, which produce IL-13 [
18,
19]. In response, epithelial cells produce the antimicrobial proteins such as SPRR2A and RELMβ. Tuft cells express several G-protein-coupled receptors (GPCRs) [
20], including bitter taste receptors (type 2 taste receptors, T2Rs), and serve as chemosensory taste cells. Luo et al., demonstrated that T2Rs in tuft cells sense luminal helminths and release IL-25 [
21]. However, the involvement of tuft cells and bitter taste receptors in dietary fiber-mediated regulation of intestinal homeostasis has not been elucidated.
The present study investigated the novel effects of psyllium fibers in regulating intestinal homeostasis via direct interaction with the intestinal epithelium in mice. In particular, we focused on the production of antimicrobial proteins via tuft cell-mediated type II immune response.
4. Discussion
Although the physiological effects of dietary fibers are often exerted through metabolism by the intestinal microbiota, direct interaction of dietary fibers with intestinal cells also regulates intestinal functions [
4,
33]. This study demonstrated that supplemental feeding of psyllium fiber upregulates antimicrobial proteins including SPRR2A and RELMβ in the small intestine of the mouse, an area where microbial activity is relatively lower than that in the colon. Our results suggested that the psyllium-mediated effect is involved in type II immunity through the tuft cell-ILC2 circuit. Bitter taste receptors expressed in tuft cells likely sense luminal psyllium fibers, eliciting an intestinal response. Recently, the regulation of type II immunity by helminths has been proposed as a therapeutic option for some immune disorders such as inflammatory bowel diseases, however, the prolonged helminth infection can cause complications [
34]. In addition, the intestinal barrier and microbiota are involved in the pathogenesis of not only intestinal diseases, but also extraintestinal diseases such as obesity and diabetes [
35]. Accordingly, the supplemental psyllium fiber may lead to the development of safe, effective, and novel therapeutic approaches for these disorders.
Psyllium supplementation increases the production of SPRR2A and RELMβ in the small intestine, indicating that psyllium fiber directly stimulates the intestinal epithelial cells in a microbiota-independent manner. Antimicrobial proteins that rapidly kill or inactivate microorganisms are among the most evolutionarily ancient immune defense mechanisms [
36]. The upregulation of antimicrobial proteins can reduce bacterial infections and alter the intestinal microbiota composition. Psyllium supplementation drastically altered cecal microflora composition in mice. Each antimicrobial protein has a specific antibacterial spectrum. SPRR2A and RELMβ selectively kill gram-positive and -negative bacteria, respectively [
13,
14]. Hu et al. demonstrated that SPRR2A-deficient mice exhibited increased levels of gram-positive bacteria in the small intestinal lumen and mucus layer [
13], and were more susceptible to infection by
Listeria monocytogenes, a pathogenic gram-positive bacterium. In contrast, RELMβ-deficient mice showed an increase in the entry of Gram-negative commensal bacteria, including Proteobacteria, into the colon inner mucus layer [
14]. Upon infection by
Citrobacter rodentium, the colonic tissue-associated bacteria in RELMβ-deficient mice were higher than that in wild type mice. This evidence suggested that the psyllium-mediated production of antimicrobial proteins such as SPRR2A and RELMβ reduces the susceptibility to bacterial infection in both physiological and pathological conditions. However, the effect of psyllium fiber on cecal microbiota composition was complex, possibly due to upregulation of other antimicrobial proteins, not just SPRR2A and RELMβ. For example, psyllium supplementation increased Muribaculaceae and decreased
Bacteroides, although both belong to gram-negative genera. In the gram-positive genera, psyllium fiber supplementation decreased several genera, whereas some genera, such as
Enterococcus, Marvinbryantia, and
[Eubacterium]_coprostanoligenes_group increased. Further research is required to determine the physiological and pathological implications of psyllium-mediated regulation of the intestinal microbiota.
Our results showed that the psyllium-mediated upregulation of SPRR2A and RELMβ is involved in the type Ⅱ immune response via the tuft cell-ILC2 circuit. Tuft cells are the primary source of IL-25 in the intestine, rapidly producing IL-25 to initiate the type Ⅱ immune response during helminth infections [
18]. The tuft cell-derived IL-25 activates ILC2 to induce the IL-13 production [
17], consequently stimulating Paneth and goblet cells to produce the antimicrobial proteins such as SPRR2A and RELMβ via the phosphorylation of a transcription factor, STAT6 [
17,
37]. In our study, psyllium supplementation increased the levels of type II immunity-related molecules such as IL-25 and IL-13 and antimicrobial proteins. In addition, an ILC2 inhibitor, disulfiram, reduced the psyllium-mediated upregulation of SPRR2A, RELMβ, STAT6 phosphorylation, IL-25, and IL-13.
Administration of bitter taste receptor blockers (probenecid, 6-methoxyflavanone, and γ-aminobutyric acid) reduced the psyllium-mediated upregulation of SPRR2A and RELMβ in mice, suggesting that the bitter taste receptors expressed in tuft cells are involved in sensing the luminal psyllium fiber. Tuft cells express several GPCRs, including bitter taste receptors (T2Rs) [
38]. Luo et al., demonstrated that T2R detects parasitic helminths, initiating type II immunity [
21]. In mice, there are at least 35
Tas2r genes, and the blockers used in the study (probenecid, 6-methoxyflavanone, and γ-aminobutyric acid) inhibit eight T2Rs viz., T2R1, 4, 7, 14, 16, 38, 39, and 47 [
23,
24,
25,
26], suggesting that tuft cells sense the luminal psyllium fiber via one or several of these TR2s. Whereas, succinate produced by helminth has been reported to activate the type II immunity through the succinate receptor (
Sucnr1) of tuft cells [
38]. However, our previous study demonstrated that supplemental psyllium fiber did not influence the succinate production in the mouse cecum [
6]. Recent single-cell RNA sequencing analysis has categorized intestinal tuft cells into two subsets: tuft-1 and tuft-2. Tuft-2 cells are specified by
Sh2d6 expression and three transcription factors:
Pou2f3, Gfi1b, and
Spib, which play a role in the development of tuft-2 cells [
31]. Psyllium supplementation increased these tuft-2 cells-related molecules, and not the tuft-1 cell marker
Tppp3. This suggested that tuft-2 cells sense luminal psyllium as a chemosensor to mediate type II immune responses and the production of antimicrobial proteins in the small intestine. Similarly, [
31] demonstrated that tuft-2 cells sense the bacterial metabolite, N-undecanoyl glycine, via another GPCR, Vmn2r26, to exert antimicrobial immunity.
Although this study revealed some mechanisms underlying psyllium fiber-induced antimicrobial proteins in the small intestine, some limitations are to be addressed in future studies. First, this study was conducted exclusively in mice, necessitating the investigation of psyllium-mediated effects in humans. Second, the specific bitter taste receptors that sense psyllium fibers remain unclear, and understanding the molecular interactions between psyllium fibers and these receptors is essential.
Figure 1.
Psyllium supplementation increases antimicrobial protein expression in mouse small intestine. Mice were fed the control and a 10% psyllium diet for 5 d, and jejunal samples were collected. Total RNA from these samples was subjected to RNA sequencing and qRT-PCR. Data (transcripts per million, TPM) were log 2 transformed after the addition of 1 for TPM, and the MA plot is shown (A). “Average” represents the mean values of the control and 10% psyllium groups. “Minus” represents the differences between values of the control and 10% psyllium groups. Each dot indicates a specific gene, and red and blue dots indicate genes >2-fold higher or lower in the 10% psyllium group than those in the control group, respectively. Heatmap shows the Z-scores of the genes encoding antimicrobial proteins (B). Srpp2a and Retnlb mRNA expression levels were determined using qRT-PCR (C, D). Protein expression of levels of SPRR2A and RELMβ were examined using immunoblot (E, F) and immunofluorescence (G, H) analyses. Results are shown as the mean ± SEM; n = 8. Statistical analysis was performed using unpaired Student’s t-test, *p <0.05.
Figure 1.
Psyllium supplementation increases antimicrobial protein expression in mouse small intestine. Mice were fed the control and a 10% psyllium diet for 5 d, and jejunal samples were collected. Total RNA from these samples was subjected to RNA sequencing and qRT-PCR. Data (transcripts per million, TPM) were log 2 transformed after the addition of 1 for TPM, and the MA plot is shown (A). “Average” represents the mean values of the control and 10% psyllium groups. “Minus” represents the differences between values of the control and 10% psyllium groups. Each dot indicates a specific gene, and red and blue dots indicate genes >2-fold higher or lower in the 10% psyllium group than those in the control group, respectively. Heatmap shows the Z-scores of the genes encoding antimicrobial proteins (B). Srpp2a and Retnlb mRNA expression levels were determined using qRT-PCR (C, D). Protein expression of levels of SPRR2A and RELMβ were examined using immunoblot (E, F) and immunofluorescence (G, H) analyses. Results are shown as the mean ± SEM; n = 8. Statistical analysis was performed using unpaired Student’s t-test, *p <0.05.
Figure 2.
Psyllium supplementation alters the microbiome profile in the mouse cecum. Mice were fed the control and a 10% psyllium diet for 5 d, and fresh cecal samples were subjected to 16S rRNA sequencing. The number of observed species (A), Chao1 index (B), and Shannon index (C) of the cecal microbiota were calculated. Principal coordinate analysis (PCoA) plots of intestinal microbiota were generated based on weighted UniFrac (D), unweighted UniFrac (E), and Bray–Curtis metrics (F) using QIIME. (G) Relative abundance of cecal microbiota at the phylum level. Genera with statistically significant differences observed between groups are shown (H, I). The genera representing relative abundances >5% (H) and 1% (I) in either group are shown. Results are shown as the mean ± SEM, n = 8. Statistical analysis was performed using unpaired Student’s t-test, *p <0.05.
Figure 2.
Psyllium supplementation alters the microbiome profile in the mouse cecum. Mice were fed the control and a 10% psyllium diet for 5 d, and fresh cecal samples were subjected to 16S rRNA sequencing. The number of observed species (A), Chao1 index (B), and Shannon index (C) of the cecal microbiota were calculated. Principal coordinate analysis (PCoA) plots of intestinal microbiota were generated based on weighted UniFrac (D), unweighted UniFrac (E), and Bray–Curtis metrics (F) using QIIME. (G) Relative abundance of cecal microbiota at the phylum level. Genera with statistically significant differences observed between groups are shown (H, I). The genera representing relative abundances >5% (H) and 1% (I) in either group are shown. Results are shown as the mean ± SEM, n = 8. Statistical analysis was performed using unpaired Student’s t-test, *p <0.05.
Figure 3.
Psyllium supplementation upregulates antimicrobial proteins, SPRR2A and RELMβ in mouse jejunum and ileum. Mice were fed diets with and without psyllium fiber (2.5, 5, 10%) for 5 d. Jejunal and ileal samples were subjected to qRT-PCR and immunoblotting. mRNA expression levels of Sprr2a (A, E) and Retnlb (C, G) levels were determined in the mouse jejunum (A, C) and ileum (E, G) using qRT-PCR. Protein expression levels of SPRR2A (B, F) and RELMß (D, H) were determined in the mouse jejunum (B, D) and ileum (F, H) by immunoblot analysis. Results are shown as the mean ± SEM; n = 6. Statistical analysis was performed using the Tukey–Kramer post-hoc test and Steel–Dwass test, *p <0.05.
Figure 3.
Psyllium supplementation upregulates antimicrobial proteins, SPRR2A and RELMβ in mouse jejunum and ileum. Mice were fed diets with and without psyllium fiber (2.5, 5, 10%) for 5 d. Jejunal and ileal samples were subjected to qRT-PCR and immunoblotting. mRNA expression levels of Sprr2a (A, E) and Retnlb (C, G) levels were determined in the mouse jejunum (A, C) and ileum (E, G) using qRT-PCR. Protein expression levels of SPRR2A (B, F) and RELMß (D, H) were determined in the mouse jejunum (B, D) and ileum (F, H) by immunoblot analysis. Results are shown as the mean ± SEM; n = 6. Statistical analysis was performed using the Tukey–Kramer post-hoc test and Steel–Dwass test, *p <0.05.
Figure 4.
Psyllium supplementation promotes tuft cell proliferation and the ILC2 immune response. Mice were fed diets with and without psyllium fiber (2.5, 5, 10%) for 5 d, and jejunal samples were subjected to qRT-PCR, immunoblot, and immunofluorescence analyses. mRNA expression levels of Pou2f3 (A), Dclk1 (B), Gfi1b (C), Sh2d6 (D), Tppp3 (E), Spib (F), Il25 (H), Il13 (I), and Il4 (J) were determined using qRT-PCR. A tuft cell marker, DCLK1, in the mouse jejunum was visualized via immunofluorescence (Scale bar: 200 µm), and the number of DCLK1+ tuft cells in a villus was quantified (G). pSTAT6 protein expression in mouse jejunum was determined using immunoblot analysis (K). Results are shown as the mean ± SEM; n = 6. Statistical analyses were performed using the Tukey–Kramer post-hoc test and unpaired Student’s t-test; *p <0.05.
Figure 4.
Psyllium supplementation promotes tuft cell proliferation and the ILC2 immune response. Mice were fed diets with and without psyllium fiber (2.5, 5, 10%) for 5 d, and jejunal samples were subjected to qRT-PCR, immunoblot, and immunofluorescence analyses. mRNA expression levels of Pou2f3 (A), Dclk1 (B), Gfi1b (C), Sh2d6 (D), Tppp3 (E), Spib (F), Il25 (H), Il13 (I), and Il4 (J) were determined using qRT-PCR. A tuft cell marker, DCLK1, in the mouse jejunum was visualized via immunofluorescence (Scale bar: 200 µm), and the number of DCLK1+ tuft cells in a villus was quantified (G). pSTAT6 protein expression in mouse jejunum was determined using immunoblot analysis (K). Results are shown as the mean ± SEM; n = 6. Statistical analyses were performed using the Tukey–Kramer post-hoc test and unpaired Student’s t-test; *p <0.05.
Figure 5.
ILC2 is involved in psyllium-induced antimicrobial protein expression. Mice were fed control and 5% psyllium diets for 5 d. An ILC2 inhibitor, disulfiram, was administered orally at 1.2 and 2.4 mg/g body weight 2 d before the start of the test diets. Jejunal samples were subjected to qRT-PCR, immunoblot, and immunofluorescence analyses. mRNA expression levels of Sprr2a (A), Retnlb (D), Pou2f3 (G), Il25 (H), and Il13 (J) in the mouse jejunum was determined using qRT-PCR analysis. Protein expression levels of SPRR2A (B), RELMβ (E), and pSTAT6 (K) were determined by immunoblot analysis. Expression of SPRR2A (C), RELMβ (F), DCLK1 (I), and pSTAT6 (L) was visualized using immunofluorescent analysis (Scale bar: 200 µm). Results are shown as the mean ± SEM; n = 7. Statistical analysis was performed using the Tukey–Kramer post-hoc test, *p <0.05.
Figure 5.
ILC2 is involved in psyllium-induced antimicrobial protein expression. Mice were fed control and 5% psyllium diets for 5 d. An ILC2 inhibitor, disulfiram, was administered orally at 1.2 and 2.4 mg/g body weight 2 d before the start of the test diets. Jejunal samples were subjected to qRT-PCR, immunoblot, and immunofluorescence analyses. mRNA expression levels of Sprr2a (A), Retnlb (D), Pou2f3 (G), Il25 (H), and Il13 (J) in the mouse jejunum was determined using qRT-PCR analysis. Protein expression levels of SPRR2A (B), RELMβ (E), and pSTAT6 (K) were determined by immunoblot analysis. Expression of SPRR2A (C), RELMβ (F), DCLK1 (I), and pSTAT6 (L) was visualized using immunofluorescent analysis (Scale bar: 200 µm). Results are shown as the mean ± SEM; n = 7. Statistical analysis was performed using the Tukey–Kramer post-hoc test, *p <0.05.
Figure 6.
Bitter taste receptors are involved in the psyllium-induced antimicrobial protein expression. Mice were fed control and 5% psyllium diets with and without bitter taste receptor blocker cocktail (0.25 and 0.5 %) for 5 d. Jejunal samples were subjected to qRT-PCR, immunoblot, and immunofluorescence analyses. mRNA expression levels of Sprr2a (A), Retnlb (D), Pou2f3 (G), Il25 (H), and Il13 (J) in the mouse jejunum was determined using qRT-PCR analysis. Protein expression levels of SPRR2A (B), RELMβ (E), and pSTAT6 (K) were determined using immunoblot analysis. Expression of SPRR2A (C), RELMβ (F), DCLK1 (I), and pSTAT6 (L) was visualized using immunofluorescent analysis (Scale bar:200 µm). Results are shown as the mean ± SEM; n = 7. Statistical analysis was performed using the Tukey–Kramer post-hoc test, *p <0.05.
Figure 6.
Bitter taste receptors are involved in the psyllium-induced antimicrobial protein expression. Mice were fed control and 5% psyllium diets with and without bitter taste receptor blocker cocktail (0.25 and 0.5 %) for 5 d. Jejunal samples were subjected to qRT-PCR, immunoblot, and immunofluorescence analyses. mRNA expression levels of Sprr2a (A), Retnlb (D), Pou2f3 (G), Il25 (H), and Il13 (J) in the mouse jejunum was determined using qRT-PCR analysis. Protein expression levels of SPRR2A (B), RELMβ (E), and pSTAT6 (K) were determined using immunoblot analysis. Expression of SPRR2A (C), RELMβ (F), DCLK1 (I), and pSTAT6 (L) was visualized using immunofluorescent analysis (Scale bar:200 µm). Results are shown as the mean ± SEM; n = 7. Statistical analysis was performed using the Tukey–Kramer post-hoc test, *p <0.05.